NEW YORK, NY
Flatiron Health announced today that The Center for Cancer and Blood Disorders, a comprehensive community oncology practice with nine locations in the Fort Worth, Texas region, selected OncoEMR® as their medical oncology electronic health record solution to support long-term value-based care initiatives and meet the practice’s evolving technology needs.
“As one of the only remaining large, independent oncology practice’s in the Fort Worth area, we strive to stay on the cutting edge of oncology so we can provide our patients with the high quality, integrated care they deserve while meeting the new value-based care reporting requirements,” said Barry Russo, chief executive officer, The Center for Cancer and Blood Disorders. “Flatiron Health has the engineering expertise to innovate and adapt quickly with us, plus a level of oncology background that we have yet to see in other software companies.”
OncoEMR is one of the most advanced cloud-based electronic health records (EHR) currently available for medical oncology. First launched in 2004, OncoEMR is designed by a leading engineering and clinical team that regularly innovates to deliver the most sophisticated point of care tools. In addition, OncoEMR automates key value-based care reporting requirements to support efficient and successful participation in alternative payment models like the Oncology Care Model.
“By utilizing OncoEMR, we will now have access to all patient information in one place, which not only enhances clinical decision-making but also the quality of care we can provide to our patients,” said Ray Page, DO, PhD, The Center for Cancer and Blood Disorders. “Additionally, OncoEMR is the best choice for us because it’s an innovative, medical oncology focused solution that will soon be interoperable with our radiation oncology software to streamline operational efficiencies.”
About Flatiron Health
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.
